CTX — Captor Therapeutics SA Share News
0.000.00%
Last trade - 00:00- PLN495.56m
- PLN480.87m
- PLN4.66m
Brief: Captor Therapeutics Submits Application For Phase 1 Clinical Trial in Patients With Hepatocellular Carcinoma
Brief: Captor Therapeutics Signs 6.8 Mln Zloty Subsidy Deal With NCBR
Brief: Captor Therapeutics Signs 5.0 Mln Zloty Subsidy Deal
Brief: Captor Therapeutics FY Net Loss Widens To 70.6 Mln Zlotys
Brief: Captor Therapeutics CFO Radoslaw Krawczyk Resigns
Brief: Captor Therapeutics 9-Month Net Loss Widens To 59.1 Mln Zlotys
Brief: Captor Therapeutics Says Total Cost Of P Series Issue At About 1.1 Mln Zlotys Net
Brief: Captor Therapeutics Allocates 400,000 P Series Shares
Brief: Captor Therapeutics Sets Price Of P Series Shares At 100 Zlotys/Shr
Brief: Captor Therapeutics Starts ABB For Up To 0.4 Mln P Series Shares
Brief: Captor Therapeutics H1 Net Loss Widens To 43.3 Mln Zlotys
Brief: Captor Therapeutics: Board May Issue 1,222,467 Shares For Investment Capital
Brief: Captor Therapeutics Signs Up To 52.2 Mln Zloty Subsidy Deal With Medical Research Agency
Brief: Captor Therapeutics Project Gets Recommended For 52.2 Mln Subsidy By Medical Research Agency
Brief: Captor Therapeutics Publishes Q1 2023 Financial Results
Brief: Captor Therapeutics Q1 Net Loss Widens To 14.2 Mln Zlotys
Brief: Captor Therapeutics Seeks NASDAQ Entry Under Strategic Plans Update
Brief: Captor Therapeutics Reports Q3 2022 Results
Brief: Captor Therapeutics Q3 Net Loss Narrows To 8.5 Mln Zlotys